ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type | Year |
State |
|---|---|---|---|---|
| Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma | University of California, San Diego / Alice Yu, MD, PhD | Innovation Grants | 2011 | California |
| Enhancing TKI Therapy in Ph-Like Leukemia | The Regents of the University of California, Irvine / David Fruman, PhD | Reach Grants | 2022 | California |
| MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis | Stanford University / Feng Pan, PhD | Young Investigator Grants | 2019 | California |
| Determinants of Testicular Germ Cell Tumor Platinum Sensitivity and Resistance | University of California, San Diego / Paolo Abada | Young Investigator Grants | 2012 | California |
| 131 I-MIBG Imaging and Therapy for Neuroblastoma: Infrastructure Proposal | University of California San Francisco / Katherine Matthay, MD | Phase I/II Infrastructure Grants | 2010 | California |
| Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture | Children's Hospital Los Angeles / Theresa Harned, MD | Young Investigator Grants | 2006 | California |
| Single-cell RNA-seq Profiling of Transcriptional Transition States During Human Retinoblastoma | Children's Hospital Los Angeles / Sunhye Lee, PhD | Young Investigator Grants | 2016 | California |
| Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias | University of California at Santa Cruz / Camilla Forsberg, PhD | Innovation Grants | 2013 | California |
| Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas | University of California, Davis Medical Center / Paul Knoepfler, PhD | Innovation Grants | 2015 | California |
| Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma | University of California San Francisco / William Weiss, MD/PhD | Innovation Grants | 2018 | California |